Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Advanced Non-small Cell Lung Cancer × Dabigatran × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 1 Neoplasms 1 Cushing Syndrome 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Advanced Non-small Cell Lung Cancer 1

Interventions

tislelizumab 1 pembrolizumab 1 osimertinib 1 aflutinib 1 Rosuvastatin Calcium 1 RO5126766 1 Midazolam 1 Food 1 Esomeprazole 1 Drug Therapy 1 Docetaxel 1 Dabigatran 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06329895 2024-07-05

A Study to Learn About How BAY2927088 Affects the Level of Dabigatran or Rosuvastatin in the Blood When These Drugs Are Taken Together in Healthy Participants

Bayer

Phase 1 Completed

Advanced Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡